Antimicrobials therapy of anaerobic infections. (3rd May 2016)

• Record Type: Journal Article
• Authors: Brook, Itzhak
• Is Part Of: Journal of chemotherapy. Volume 28:Number 3(2016:Jun.)
• Page Start: 143
• Page End: 150
• Publication Date: 2016-05-03
• Subjects: Anaerobes -- Bacteroides fragilis -- Antimicrobial resistance -- Antibiotics; Chemotherapy -- Periodicals; Drug Therapy -- Periodicals; 615.58
• DOI: 10.1179/1973947815Y.0000000068
• Languages: English
• ISSNs: 1120-009X

Abstract

Abstract : Anaerobes predominant in the normal human skin and mucous membranes bacterial flora are often a cause of endogenous infections. Anaerobic bacteria are difficult to isolate from infectious sites, and are often overlooked. Anaerobic infections caused by anaerobes can occur in all body sites, including the central nervous system (CNS), oral cavity, head and neck, chest, abdomen, pelvis, skin and soft tissues. The treatment of these infections is complicated by the slow growth of these organisms, their polymicrobial nature and the growing resistance of anaerobes to antimicrobials agents. Antimicrobials are frequently the only form of therapy needed, but in others, they are an important adjunct to surgical drainage and correction of pathology. Because anaerobes are often recovered with aerobic and facultative bacteria, the chosen antimicrobials should cover all pathogens. The antimicrobials effective against anaerobic organisms are metronidazole, carbapenems, combinations of a beta-lactam and a beta-lactamase inhibitor, chloramphenicol, tigecycline and clindamycin.